PURPOSE. To test the hypothesis that extracellular matrix turnover, mediate
d by the matrix metalloproteinases, modulates aqueous humor outflow facilit
y in a human outflow model.
METHODS. Matrix metalloproteinase activity was manipulated and outflow faci
lity evaluated using perfused human anterior segment organ culture. Purifie
d matrix metalloproteinases, tissue inhibitors of metalloprotienases (TIMPs
), and several families of synthetic inhibitors of matrix metalloproteinase
s were added to the perfusion medium. Matrix metalloproteinase expression w
as increased by adding recombinant interleukin (IL)-1 alpha. Kinetic inhibi
tion analysis was conducted for stromelysin, gelatinase A, and gelatinase B
with the various inhibitors. Live-dead staining was used to evaluate cultu
re viability.
RESULTS. Increasing metalloproteinase activity, by adding purified metallop
roteinases or by inducing their expression by IL-1 alpha treatment, increas
ed outflow facility. Inhibition of endogenous trabecular metalloproteinase
activity using TIMP or several families of synthetic metalloproteinase inhi
bitors reduced outflow rates. The elevation and the reduction of outflow ra
tes were reversible, with changes requiring 1 to 3 days. Kinetic enzyme inh
ibition analysis produced 50% inhibitory concentration values for these inh
ibitors that were compatible with the concentration ranges for outflow inhi
bition.
CONCLUSIONS. The ability of several specific matrix metalloproteinase inhib
itors to reduce outflow facility implies that endogenous extracellular matr
ix turnover by these enzymes was required for the maintenance of trabecular
outflow resistance, at least in this human culture model. These observatio
ns provide support for the hypothesis that controlled extracellular matrix
turnover is important in the regulation of aqueous humor outflow facility.